FILINGS
| INZY 0001693011 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2023-03-22 | 10-K | 10-K | View Document |
| 2023-03-22 | 8-K | 8-K | View Document |
| 2023-03-10 | 8-K | 8-K | View Document |
| 2023-03-07 | SC 13G | SC 13G | View Document |
| 2023-02-16 | 8-K | 8-K | View Document |
| 2023-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2023-02-14 | SC 13G | SC 13G | View Document |
| 2023-02-14 | SC 13G/A | View Document | |
| 2023-02-14 | SC 13G/A | View Document | |
| 2023-02-13 | SC 13G | CHI ADVISORS LLC | View Document |
| 2023-02-10 | SC 13G/A | View Document | |
| 2023-02-09 | SC 13G/A | INOZYME PHARMA, INC. | View Document |
| 2022-12-19 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-12-08 | 8-K | 8-K | View Document |
| 2022-12-08 | 8-K | 8-K | View Document |
| 2022-11-10 | 10-Q | 10-Q | View Document |
| 2022-11-10 | 8-K | 8-K | View Document |
| 2022-10-04 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-10-04 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-08-15 | 10-Q | 10-Q | View Document |
| 2022-08-15 | 8-K | 8-K | View Document |
| 2022-07-26 | 8-K | 8-K | View Document |
| 2022-07-19 | 8-K | 8-K | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-14 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-06-10 | 8-K | 8-K | View Document |
| 2022-05-10 | 10-Q | 10-Q | View Document |
| 2022-05-10 | 8-K | 8-K | View Document |
| 2022-04-29 | SC 13G | SC 13G | View Document |
| 2022-04-28 | SC 13D | SC 13D | View Document |
| 2022-04-28 | SC 13D/A | SC 13D/A | View Document |
| 2022-04-27 | DEFA14A | DEFA14A | View Document |
| 2022-04-27 | DEF 14A | DEF 14A | View Document |
| 2022-04-25 | SC 13G | View Document | |
| 2022-04-21 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-04-20 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | View Document |
| 2022-04-20 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-04-20 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-04-20 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-04-20 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-04-19 | 8-K | 8-K | View Document |
| 2022-04-18 | SC 13G | View Document | |
| 2022-04-14 | 424B5 | 424B5 | View Document |
| 2022-04-12 | 8-K | 8-K | View Document |
| 2022-04-04 | 8-K | 8-K | View Document |
| 2022-03-31 | 10-K/A | 10-K/A | View Document |
| 2022-03-22 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-03-22 | 3 | FORM 3 SUBMISSION | View Document |
| 2022-03-15 | 8-K | 8-K | View Document |
| 2022-03-15 | S-8 | S-8 | View Document |
| 2022-03-15 | 10-K | 10-K | View Document |
| 2022-03-08 | 8-K | 8-K | View Document |
| 2022-02-28 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-02-28 | 4 | FORM 4 SUBMISSION | View Document |
| 2022-02-14 | SC 13G/A | SC 13G/A | View Document |
| 2022-02-11 | SC 13G/A | View Document | |
| 2022-02-10 | SC 13G/A | INOZYME PHARMA, INC. | View Document |
| 2022-02-07 | SC 13G/A | NEW ENTERPRISE ASSOCIATES 15, L.P. / INOZYME PHARMA -- 13GA(#1) | View Document |
| 2021-11-15 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2021-11-15 | 8-K | 8-K | View Document |
| 2021-11-09 | 10-Q | 10-Q | View Document |
| 2021-11-09 | 8-K | 8-K | View Document |
| 2021-08-23 | EFFECT | View Document | |
| 2021-08-19 | CORRESP | View Document | |
| 2021-08-18 | UPLOAD | View Document | |
| 2021-08-11 | S-3 | S-3 | View Document |
| 2021-08-11 | 10-Q | INZY_10-Q_6312021 | View Document |
| 2021-08-11 | 8-K | 8-K | View Document |
| 2021-07-30 | SC 13D/A | SC 13D/A | View Document |
| 2021-06-25 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-25 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-06-24 | 8-K | 8-K | View Document |
| 2021-05-18 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-05-18 | 3 | FORM 3 SUBMISSION | View Document |
| 2021-05-12 | 10-Q | 10-Q | View Document |
| 2021-05-12 | 8-K | 8-K | View Document |
| 2021-05-10 | SC 13G | INOZYME PHARMA, INC. | View Document |
| 2021-05-07 | 8-K | 8-K | View Document |
| 2021-04-27 | DEFA14A | DEFA14A | View Document |
| 2021-04-27 | DEF 14A | DEF 14A | View Document |
| 2021-04-21 | 8-K | 8-K | View Document |
| 2021-03-30 | SC 13D/A | SC 13D/A | View Document |
| 2021-03-25 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-03-25 | S-8 | S-8 | View Document |
| 2021-03-25 | 10-K | 10-K | View Document |
| 2021-03-25 | 8-K | 8-K | View Document |
| 2021-03-17 | 4 | FORM 4 SUBMISSION | View Document |
| 2021-03-17 | 4 | FORM 4 SUBMISSION | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
